Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LLIMA
PACTR202610648935132Phase 3Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ivermectin and albendazole in malaria (2 arms), sponsored by University of Oxford. Planned start Apr 2028; status: not yet recruiting.
02
Drugs
ivermectinalbendazole
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202610648935132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610648935132.